1차 출처 기록

pembrolizumab · NCT06295731 레지스트리 업데이트

상태: ACTIVE_NOT_RECRUITING → RECRUITING; 주요 완료: 2029-05 → 2029-12; 완료: 2029-05 → 2031-05; 등록: 410 → 450; 주요 결과: ['Phase 2: Objective Response Rate (ORR)', 'Phase 3: Progression-Free Survival (PFS)', 'Phase 3: Overall Survival (OS)'] → ['Phase 2: Objective Response Rate by investigator (ORRinv)', 'Phase 3: Progression-Free Survival by Investigator (PFSinv)', 'Phase 3: Overall Survival (OS)']; 국가: {'total_sites': 87, 'us_sites': 25} → {'total_sites': 89, 'us_sites': 26}